Variation in Locoregional Prostate Cancer Care and Treatment Trends at Commission on Cancer Designated Facilities: A National Cancer Data Base Analysis 2004 to 2013-Reference-Cited by-同舟云学术

Variation in Locoregional Prostate Cancer Care and Treatment Trends at Commission on Cancer Designated Facilities: A National Cancer Data Base Analysis 2004 to 2013

Published:2017-12 Issue:6 Volume:15 Page:e955-e968
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Löppenberg Björn^ORCID,Sood Akshay,Dalela Deepansh,Karabon Patrick,Sammon Jesse D.,Vetterlein Malte W.,Noldus Joachim,Peabody James O.,Trinh Quoc-Dien,Menon Mani,Abdollah Firas^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference38 articles.

1. Cancer Facts & Figures 2017,2017

2. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities;Kramer;Clin Prostate Cancer,2005

3. Urologists' use of intensity-modulated radiation therapy for prostate cancer;Mitchell;N Engl J Med,2013

4. Reimbursement policy and androgen-deprivation therapy for prostate cancer;Shahinian;N Engl J Med,2010

5. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer;Daskivich;Cancer,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Admission Rates, Healthcare Utilization, and Inpatient Cost of Radiation Cystitis in the United States;Urology;2023-12

2. F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer;BJU International;2023-09-15

3. 15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer;Prostate Cancer and Prostatic Diseases;2023-05-04

4. Evaluating post radical prostatectomy mechanisms of early continence;The Prostate;2022-05-17

5. Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact® Survey 2018;Cancer Management and Research;2021-12